BRICKELL BIOTECH
BRICKELL BIOTECH
Share · US10802T1051 · BBI · A2PRDX (LSSI)
Overview Financial Indicators
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - 4,90 % 7,33 % 71,16 %

Company Profile for BRICKELL BIOTECH Share

Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary axillary hyperhidrosis; BBI-02, an oral DYRK1A inhibitor for the treatment of autoimmune and inflammatory diseases; and BBI-10, a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases, as well as next-generation kinase inhibitors. It has license and collaboration agreements with Carna Biosciences, Inc., Voronoi Inc., Bodor Laboratories, Inc. and Dr. Nicholas S. Bodor, and AnGes, Inc. The company was founded in 2009 and is headquartered in Boulder, Colorado.

Company Data

Name BRICKELL BIOTECH
Company Brickell Biotech, Inc.
Symbol BBI
Website https://www.brickellbio.com
Primary Exchange LSSI Lang & Schwarz
WKN A2PRDX
ISIN US10802T1051
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Robert Brown
Country United States of America
Currency EUR
Employees 0,0 T
Address 5777 Central Ave Ste 102, 80301 Boulder
IPO Date 1993-03-10

Stock Splits

Date Split
05.07.2022 1:45
03.09.2019 1:7
27.05.2016 1:10

ID Changes

Date From To
03.09.2019 VICL BBI

Ticker Symbols

Name Symbol
NASDAQ BBI

More Shares

Investors who BRICKELL BIOTECH hold also have the following shares in their portfolio:
HANETF-GCENCROF DLA
HANETF-GCENCROF DLA ETF
RUSSIAN FED. 12/42 REGS
RUSSIAN FED. 12/42 REGS Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025